MedPark Regeneration First

R&D

  • Technology

  • Facility

  • Certification

S1 Technology

Own Original Technology

Composite bone grafting material composed of chemically and structurally treated
hydroxyapatite and additives with a natural structure similar to human bone,
it has osteoconductive property to help bone regeneration at the grafted site.
Core technology applicable to all medical fields (orthopedics, neurology, dentistry, etc.)
and raw materials (xenogeneic, allogeneic, synthetic)

Facility

1, 2, 3 Factory construction completed

World's First, The European CE certificate of 3 items Separate biomaterial
manufacturing facilities for different raw materials in factory 1~3

  • 1st Factory / HQ

    [Bone Graft Material Line]
  • 2nd Factory / R&D Center

    [Bone Graft + Collagen Line]
  • 3rd Factory

    [Artificial Skin + Other Medical Field]

R&D Facilities / Certifications / Patents

Commercialized technology Global IP (intellectual property rights)
holding a total of 46 or more

Overseas
23

PCT application

2

US application

6

European application

6

China application

6

Taiwan application

5

Madrid trademark application

1

Chinese design application

1
0or more in total

Domestic
23

Domestic Patent

3

Domestic application

11

Domestic trademark registration

1

Domestic trademark application

1

Domestic design registration

2

Domestic design application

1